Article
Mutations in SARS-CoV-2 are on the increase against the acquired immunity.
PloS one - 1 Jan 2022
Konishi Tomokazu
Abstract excerpt
Monovalent vaccines using mRNA or adenoviruses have provided substantial protection against the COVID-19 pandemic in many countries. However, viral mutations have hampered the efficacy of this approach. The Omicron variant, which appeared in Dec 2021, has caused a pandemic that has exerted pressure on the healthcare system worldwide. The COVID-19 vaccines are not very effective against this variant, resulting in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
